Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.

Poly(lactic-co-glycolic-acid) nanoparticles are often produced using the w/o/w emulsification solvent evaporation method. In most cases poly(vinyl alcohol) (PVA) is used as stabilizer of the emulsion. The goal of this study was to compare a series of polymers to PVA in a 2(2) full factorial design study. The influence of the concentration of PVA and the polymers tested on particle size and zeta potential value was evaluated before and after freeze-drying of the prepared particles. Nanoparticles were obtained with most polymers when they were used in combination with PVA. Leaving PVA out of the formulation, however, increased the size of the particles over 1 microm. Two exceptions are poloxamer and carbopol, which can be considered as valuable alternatives to PVA. Zeta potential values were usually slightly negative, the most extreme zeta potential values were measured when poloxamer and carbopol were employed. The use of gelatin type A made it possible to achieve positive values. The original 2(2) full factorial design study was further expanded to a central composite design for poloxamer and carbopol, in order to fit the measured data to a quadratic model and to calculate response surfaces.

[1]  M. Alonso,et al.  Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration , 1998, Pharmaceutical Research.

[2]  A. Ludwig,et al.  Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study. , 2001, Die Pharmazie.

[3]  Y. Ikada,et al.  Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. , 1992, Investigative ophthalmology & visual science.

[4]  R. Gurny,et al.  Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. , 1997, Pharmaceutica acta Helvetiae.

[5]  Y. Kawashima,et al.  Mucoadhesive nanoparticulate systems for peptide drug delivery. , 2001, Advanced drug delivery reviews.

[6]  A. Coombes,et al.  Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics , 1997 .

[7]  David R. Pichora,et al.  A mechanistic study of antibiotic release from biodegradable poly(d,1-lactide) cylinders , 1994 .

[8]  S. Santoyo,et al.  Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[9]  H Fessi,et al.  Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. , 1998, Journal of microencapsulation.

[10]  M. Wirth,et al.  Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. , 1999, Journal of microencapsulation.

[11]  Y. Ikada,et al.  Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. , 1991, Investigative ophthalmology & visual science.

[12]  M C Davies,et al.  Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[13]  U. Kompella,et al.  Preparation of drug delivery systems using supercritical fluid technology. , 2001, Critical reviews in therapeutic drug carrier systems.

[14]  T. Chandy,et al.  Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. , 2000, Drug delivery.

[15]  M. L. La Rotonda,et al.  Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[16]  M. Blanco-Prieto,et al.  Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. , 1997, Advanced drug delivery reviews.

[17]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[18]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  J. S. Hunter,et al.  Statistics for experimenters : an introduction to design, data analysis, and model building , 1979 .

[20]  J. Robinson,et al.  Study of the mechanism of interaction of poly(ϵ-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy , 1994 .

[21]  Anthony J. Hickey,et al.  Respirable PLGA Microspheres Containing Rifampicin for the Treatment of Tuberculosis: Manufacture and Characterization , 2000, Pharmaceutical Research.

[22]  R. Arshady Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters , 1991 .

[23]  M. Refojo,et al.  Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. , 1997, Investigative ophthalmology & visual science.

[24]  A. Zimmer,et al.  Studies on the transport pathway of PBCA nanoparticles in ocular tissues. , 1991, Journal of microencapsulation.

[25]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[26]  P. Sansdrap,et al.  Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres , 1993 .

[27]  Robert J. Linhardt,et al.  Influence of formulation methods on the in vitro controlled release of protein from poly (ester) microspheres , 1991 .